NCT05484219

Brief Summary

The purpose of the study is to assess accuracy, advantages of functional neuronavigation and calculate safe distance from motor areas to brain tumors and vascular malformations in image-guided surgery.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started Sep 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Sep 2022Aug 2027

First Submitted

Initial submission to the registry

July 29, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 2, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2022

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2027

Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

5 years

First QC Date

July 29, 2022

Last Update Submit

May 13, 2025

Conditions

Keywords

brain tumorarteriovenous malformationcavernomacavernous malformationfunctional navigation

Outcome Measures

Primary Outcomes (2)

  • Accuracy of functional navigation (in millimeters)

    Maximal distance from the most remote margin of cortical hand/leg motor area or corticospinal tract in the area of corona radiata in functional navigation to the nearest margin of this area/tract in direct cortical/subcortical stimulation

    Intraoperatively

  • Accuracy of location of cortical hand/leg motor area, built according to tractography (in millimeters)

    Maximal distance from the most remote margin of cortical hand/leg motor area, built according to tractography and loaded into navigation, to the nearest margin of this area in direct cortical stimulation

    Intraoperatively

Secondary Outcomes (9)

  • Constancy of location of cortical hand/leg motor area in fMRI/TMS in relation to precentral gyrus (in millimeters)

    Within 2 days before surgery

  • Factors, violating precision of fMRI/TMS/tractography

    Within 2 days before surgery

  • Motor function (in grades)

    Within 10 days after surgery

  • Distance to stop resection border (in millimeters)

    Intraoperatively

  • Safe resection distance in functional navigation (in millimeters)

    Within 10 days after surgery

  • +4 more secondary outcomes

Study Arms (1)

Surgery

EXPERIMENTAL

Image-guided resection of brain tumors and vascular malformations

Device: Functional navigation

Interventions

Surgeon removes brain tumor or vascular malformation and assesses location of motor areas with functional navigation and intraoperative neuromonitoring

Surgery

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all intracranial tumors
  • arteriovenous malformations
  • cavernous malformations
  • supratentorial localization
  • newly diagnosed
  • age 18-79 years
  • unaltered consciousness
  • error of patient registration in neuronavigation no more than 2 mm
  • possibility to perform "positive mapping" strategy

You may not qualify if:

  • contraindications to magnetic resonance imaging or transcranial magnetic stimulation
  • inability to build tractography in neuronavigation
  • predicting of intraoperative brain shift 6 mm and more without possibility to correct it
  • real intraoperative brain shift 6 mm and more without possibility to correct it
  • previously performed brain radiotherapy
  • pregnancy
  • breast feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sklifosovsky Institute of Emergency Care

Moscow, 129090, Russia

Location

MeSH Terms

Conditions

Brain NeoplasmsArteriovenous MalformationsHemangioma, Capillary

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular MalformationsCardiovascular AbnormalitiesCardiovascular DiseasesVascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHemangiomaNeoplasms, Vascular TissueNeoplasms by Histologic Type

Study Officials

  • Alexander Dmitriev, MD

    Sklifosovsky Institute of Emergency Care

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 29, 2022

First Posted

August 2, 2022

Study Start

September 1, 2022

Primary Completion (Estimated)

August 31, 2027

Study Completion (Estimated)

August 31, 2027

Last Updated

May 16, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations